MedPath

Butalbital, Acetaminophen and Caffeine

Butalbital, Acetaminophen and Caffeine Tablets, USP CIII 8467265/0822 Rx only

Approved
Approval ID

c2e3eda3-d76f-4332-8260-d2b1939a229a

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Sep 15, 2025

Manufacturers
FDA

American Health Packaging

DUNS: 929561009

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

Butalbital, Acetaminophen, and Caffeine

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code60687-672
Application NumberANDA040511
Product Classification
M
Marketing Category
C73584
G
Generic Name
Butalbital, Acetaminophen, and Caffeine
Product Specifications
Route of AdministrationORAL
Effective DateSeptember 15, 2025
FDA Product Classification

INGREDIENTS (11)

SILICON DIOXIDEInactive
Code: ETJ7Z6XBU4
Classification: IACT
CROSCARMELLOSE SODIUMInactive
Code: M28OL1HH48
Classification: IACT
CROSPOVIDONEInactive
Code: 2S7830E561
Classification: IACT
MAGNESIUM STEARATEInactive
Code: 70097M6I30
Classification: IACT
MICROCRYSTALLINE CELLULOSEInactive
Code: OP1R32D61U
Classification: IACT
POVIDONE, UNSPECIFIEDInactive
Code: FZ989GH94E
Classification: IACT
STARCH, CORNInactive
Code: O8232NY3SJ
Classification: IACT
STEARIC ACIDInactive
Code: 4ELV7Z65AP
Classification: IACT
BUTALBITALActive
Quantity: 50 mg in 1 1
Code: KHS0AZ4JVK
Classification: ACTIB
ACETAMINOPHENActive
Quantity: 325 mg in 1 1
Code: 362O9ITL9D
Classification: ACTIB
CAFFEINEActive
Quantity: 40 mg in 1 1
Code: 3G6A5W338E
Classification: ACTIB

Drug Labeling Information

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LOINC: 51945-4Updated: 7/28/2022

Package/Label Display Panel – Blister - 50 mg/325 mg/40 mg

50 mg/325 mg/40 mg Butalbital, Acetaminophen and Caffeine Tablet Blister

Butalbital,CIII
Acetaminophen
and Caffeine Tablet, USP

50 mg/325 mg/40 mg

DESCRIPTION SECTION

LOINC: 34089-3Updated: 7/28/2022

DESCRIPTION

Butalbital, Acetaminophen and Caffeine Tablets, USP are supplied in tablet form for oral administration.

Each tablet contains the following active ingredients:
butalbital, USP ...................................................................................... 50 mg
acetaminophen, USP ........................................................................... 325 mg
caffeine, USP ........................................................................................ 40 mg

Inactive Ingredients: colloidal silicon dioxide, croscarmellose sodium, crospovidone, magnesium stearate, microcrystalline cellulose, povidone, pregelatinized starch, and stearic acid.

Butalbital (5-allyl-5-isobutylbarbituric acid), is a short to intermediate- acting barbiturate. It has the following structural formula:

Structural Formula Butalbital

Acetaminophen (4'-hydroxyacetanilide), is a non-opiate, non-salicylate analgesic and antipyretic. It has the following structural formula.

Structural Formula Acetaminophen

Caffeine (1,3,7-trimethylxanthine), is a central nervous system stimulant. It has the following structural formula:

Structural Formula Caffeine

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

Butalbital, Acetaminophen and Caffeine - FDA Drug Approval Details